Hannah A. D. King

Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection

Andrew I. Flyak, Xiaoli Shen, Charles D. Murin et al. · Cell · 2016 · 178 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +8

A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

Michael Joyce, Hannah A. D. King, Inès Lakhal-Naouar et al. · Science Translational Medicine · 2022 · 136 citations · Full text

Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region

Andrew I. Flyak, Natalia A. Kuzmina, Charles D. Murin et al. · Nature Microbiology · 2018 · 87 citations · Full text

Emerging Infectious Diseases, Viral Pathogenesis, Immunology +7

Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques

Hannah A. D. King, Michael Joyce, Inès Lakhal-Naouar et al. · Proceedings of the National Academy of Sciences · 2021 · 66 citations · Full text

Vaccination, Rfn Vaccination, Vaccine Development +14

AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques

Amir Dashti, Sophia Sukkestad, Anna M. Horner et al. · Nature Medicine · 2023 · 40 citations · Full text